Determiningthe infectious period of COVID-19 is complicated by four factors: 1)people can be diagnosed when they are symptomatic, pre-symptomaticor asymptomatic, 2) the common diagnostic test, RT-PCR, is accuratefor diagnosis as it is able to detect viral genetic material, but it cannot...
To clarify the potential value of shortening the infectious period, Lee and colleagues created acomputational modelthat simulates the spread of SARS-CoV-2, the virus that causes COVID-19. They used the model to explore how a vaccine ormedicationthat can reduce the contagious period might allevia...
COVID-19 is now the dominant infectious disease concern in Beijing, with the JN.1 variant being the dominant strain. While the city reported 88,971 cases of 21 infectious diseases in February 2024, including viral hepatitis, tubercu...
The IJID Coronavirus Disease 2019 (COVID-19) Collection brings together COVID-19 (SARS-CoV-2) content from the IJID as it is published. Editors for the International Journal on Infectious Diseases rapidly evaluate submitted manuscripts concerning the evolving COVID-19 pandemic. Copyediting and publ...
(HealthDay)—There was a population-wide decrease in the rate of infectious conjunctivitis in association with public health interventions adopted to curb COVID-19, according to a study published online Nov. 18 in JAMA Ophthalmology.
Experts in infectious diseases are invited to the Infectious Diseases Conferences 2022, Infection Prevention and Control Conferences, Covid 19 and Microbiology Conferences scheduled in the UK. Anticipating participation from USA, Europe, Asia, Middle Eas
Nationwide nonpharmaceutical interventions (NPIs) have been effective at mitigating the spread of the novel coronavirus disease (COVID-19), but their broad impact on other diseases remains under-investigated. Here we report an ecological analysis compari
COVID-19 HIV Influenza Pediatric indications You can count on us to deliver investigators and sites with proven trial experience. And patients remain at the center of your clinical development strategy. Our digital and decentralized trial solutions are designed to increase clinical trial access for pa...
There is limited data on outcomes among lung transplant (LT) patients who survive Coronavirus disease 2019 (COVID-19). 关于2019年新冠病毒病(COVID-19)存活下来的肺移植(LT)患者的预后数据有限。 Methods Any single or bilatera...
theCOVID-19 pandemichas been on everyone's mind, we shouldn't overlook the importance of other viral infections or the utility of viruses or viral components that can be used to serve useful and important functions. We also shouldn't minimize the influence of viral systems in research across...